SWP
NVCR icon

Stratos Wealth Partners’s NovoCure NVCR Stock Holding History

Stratos Wealth Partners’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,209
Closed -$268K – 1231
2021
Q2 		$268K Buy
+1,209
New +$235K 0.01% 1017
2021
Q1 		– Sell
-1,501
Closed -$260K – 1154
2020
Q4 		$260K Buy
+1,501
New +$205K 0.01% 901
2018
Q2 		– Sell
-5,009
Closed -$109K – 2038
2018
Q1 		$109K Buy
+5,009
New +$108K ﹤0.01% 1151

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stratos Wealth Partners's NVCR Position: Q3 2021 in Review

Stratos Wealth Partners sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 1,209 shares — an estimated $268K sold.

Stratos Wealth Partners first reported a position in NVCR in Q1 2018 and held it in 3 quarters. The position peaked at $268K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Stratos Wealth Partners reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,209 NovoCure shares in Q3 2021, an estimated $268K.
  • Stratos Wealth Partners first reported a position in NovoCure in Q1 2018 and held it in 3 quarters.
  • Stratos Wealth Partners's NovoCure position peaked at $268K in Q2 2021.
  • 317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Stratos Wealth Partners's 13F filing for Q3 2021, filed 19 Oct 2021.